The balanced manifestation of effector functions and the generation of long-living memory cells is a hallmark of efficient CD8 T cell 
Introduction
Upon antigen encounter, na ve and memory CD8 T cells with relevant specificity are driven into massive proliferation, accompanied ï + by gradual acquisition of cytotoxic effector functions , and generation of antigen-specific memory cells. Antigen clearance signals the 1 termination of the clonal expansion through apoptosis. A number of studies have shown that CD8 T cell differentiation stages may be defined by the ordered expression of certain surface receptors. Na ve CD8 T cells co-express CD45RA isoform, CD28 and CD27 ï co-stimulatory receptors, and CCR7 chemokine receptor, while antigen-primed cells gradually lose CD45RA and CD28 expression. Recirculating long-living central memory cells still express CCR7, while more differentiated effector-memory cells are CCR7 negative.
The irreversible loss of CD27 indicates decreased proliferation potential, increased cytotoxicity and definitive transition towards effector stage. Finally, CD45RA re-expression defines a terminal highly cytotoxic and apoptosis-prone stage .
-5
A hallmark of efficient CD8 T cell response is the balance between the prompt manifestation of effector functions and the generation + of long-living memory cells ; . This balance is fine-tuned by external signals and is strongly dependent on the regulatory mechanisms of 5 6 the host . Following studies in mice, recent studies in humans have shown that CD4 CD25 T cells (Treg) constitute a small 7 -9 + high fraction of CD4 T cells that plays a role of immune regulator. These cells inhibit the proliferation of T cells stimulated through their T cell receptor (TCR), and usually exert their suppressive function through contact-dependent mechanisms, though recent data suggest that these cells may also function in a cytokine-dependent manner ; . The mechanisms by which Treg exert their suppressive function are not 10 11 fully elucidated. Some groups have described an increased expression of Glucocorticoid-Induced Tumor necrosis Factor (GITR) and CTLA-4 on Treg, but so far it is not clear whether these molecules are differentiation markers or directly involved in Treg functions 12 -. 14 The effects of Treg on both CD4 and CD8 T cell responses have been largely investigated in the settings of chronic viral infections +
15
. Accumulating data evidence that this particular population might be a key factor for the inefficiency of CD8 T cell response and homeostasis of CD8 T lymphocyte subsets. In the present paper we studied the effects of Treg on T CD8 differentiation induced with + + polyclonal or antigen-specific stimulation. We looked for their effects on cytokines secretion, effector function, proliferation and apoptosis 2 17 of the different CD8 subpopulations. Finally, we investigated whether the interaction of PD-1 (CD279) and its ligand PD-L1 (CD274) is + involved in Treg-mediated effects.
Material and methods

Cell populations
Healthy donors blood was obtained after informed consent was obtained in accordance with the Declaration of Helsinki. All studies ' received institutional review board approval from the Regional Blood Transfusion Department (Creteil, France). CD8 and CD4 T cells with high intensity. In sorting experiments purified CD8 T cells were stained with CD27/CD45RA mAbs and the memory CD27
+ + CD45RA-(M) and CD27-CD45RA-Effector (E) subsets were sorted under sterile conditions. In some experiments Terminally Effector CD27-CD45RA (TE) cells were also sorted (Coulter sorter).
+°I mmunophenotyping studies
Immunophenotyping was performed using 4-color flow cytometry. Cell fractions were incubated with appropriate mAbs for 30 minutes at 4 C, washed and fixed in PBS 1 formaldehyde. The following murine monoclonal antibodies (mAbs) were purchased from°% BD Biosciences (Le Pont Claix, France): anti-CD25-FITC, anti-CD4-PerCP, anti-CD8 -PerCP, anti-CD3-APC, anti-CD27-PE, + anti-PD-1-PE, anti-PDL1-PE, anti-CD45RA-APC, anti-IL-2-PE, and anti-IFN -FITC. Anti-CD45RA Cy5 used for sorting was a product γ of Coulter. FITC-conjugated anti-CD 160 mAb was produced in one of our laboratories (INSERM U955). Isotype-matched controls were used in all phenotyping experiments.
CFSE proliferation assay
Cell cultures were performed in RPMI 1640 (Bio Whittaker Europe, Verviers, France) supplemented with 10 human blood group % AB serum (BioWest, Nuaille, France), penicillin-streptomycin (100 IU/mL and 100 g/mL, respectively), 2 mM L-glutamine (all from μ Gibco BRL, Paisley, United Kingdom), and 1 mM sodium pyruvate, (Sigma-Aldrich). CD8 T cells were washed 3 times in PBS and 3 5 + -10 cells/ml were mixed with 1 M CFSE (5,6 carboxyfluorescein diacetate succinimidyl ester, Molecular probes) in 1:1 volume ratio.
Staining was performed for 8 min at 37 C followed by 3 washes in ice-cold complete medium. For anti-CD3 stimulation, 5 g/mL°μ anti-CD3 mAb (clone UCHT1; Beckman Coulter, Marseille, France) was coated on 96-well flat-bottomed cell culture plates overnight at 4 C. CFSE-labeled CD8 T cells were cultured in the presence or absence of CD4 T cell fractions at a total cell concentration of 2.5 10°+
/ml and final volume of 200 l. Previous titration experiments showed that co-cultures (CD8/Treg) at a ratio 2:1; 4:1 and 8:1 led to 55 , μ % 40 and 22 (mean of 3 experiments) inhibition of CD8 T cell proliferation whereas no inhibition was noted in the presence of CD4 % % + CD25-. In further experiments, co-cultures were performed at a 4:1 ratio. At the end of culture, cells were washed, additionally stained with CD27/CD8/CD45RA; PD-1/CD8/CD4 or PD-L1/CD8/CD4 combinations and analyzed by flow cytometry. The percentage of Treg mediated inhibition was calculated as follows: ( CFSE in the presence of Treg/ CFSE in the absence of Treg) 100.
Cytokine assays
Procedures were performed as previously described . CD8 T cells were cultured in 48 well plates, in the presence or absence of 24 + CD4 T cell fractions at a concentration 5 10 cells/well. For antigen specific stimulation experiments, autologous monocytes were
added at 5 10 /well. Overnight stimulation was carried out with plate-bound anti-CD3 (5 g/ml) or CEF (CMV, EBV and influenza
virus) peptide mixture, 5 g/mL each. Two hours after the beginning of culture 1 l/ml Brefeldin A (5 g/mL; Sigma-Aldrich, St Louis,
Missouri, MO) was added to each well. Harvested cells were washed 2 times in PBS, surface-stained with CD3/CD8 mAb, fixed and + permeabilized by Cytofix/Cytoperm (BD Pharmingen) and stained for intracellular expression of IFN-and IL-2 (30 min at room γ temperature).
Apoptosis and Transwell studies
CD8 T cells were cultured in the presence or absence of CD4 T cell fractions in 96-well round-bottomed plates coated with
anti-CD3 at 5 g/ml. Forty eight hours later cells were harvested, washed with cold PBS, suspended in binding buffer (containing 2.5 mM with a combination of CD8 and PD-1 (AF 1086, R&D Systems) mAbs to obtain final concentrations of 5 g/ml and 20 g/ml respectively. μ μ
In Transwell experiments, CD8 T cells were seeded at 5 10 /well in the lower chamber of a 24-well plate (Cellstar) coated with 5 g/ml
anti-CD3 mAb, and were cultured in the presence of Treg, or CD4 CD25-T cells, added either in direct contact with CD8 T cells, or in + + the upper chamber (Greiner bio-one, Germany).
Flow cytometry
Cells were analyzed by a FACSCalibur flow cytometer (BD Immunocytometry systems). At least 20 10 CD8 gated events were 
Results
Treg inhibit the polyclonal and antigen-specific proliferation of CD8 T cells
+
We first studied the effects of Treg on polyclonal and antigen-specific induced proliferation of CD8 T cells. To this end, CD8 , CD4
+ + CD25-and CD4 CD25 T cells from 11 healthy donors were purified. We verified that CD4 CD25 Treg cells expressed high levels
of the transcription factor FoxP3 (Sup. Fig. 1 ). CD8 T cells were labeled with CFSE and stimulated with plate-bound anti-CD3 mAb for 
Treg inhibit the differentiation of effector CD8 T cells
Next, we evaluated the effects of Treg on the differentiation of activated CD8 T cells. For this, experiments were performed either + with total CD8 T cells or sorted CD8 populations. We defined CD8 T cells subsets according to the co-expression of CD45RA and CD27 + and further studied the expression of CCR7, CD28, and the cytotoxic CD160 receptor in these subsets (Sup. Fig. 2 ). Based on this analysis, CD27 CD4RA-CD8 T cells were mostly CCR7 CD28 , while CD27 CD45RA-CD8 T cells contained exclusively CCR7-cells,
and a variable proportion of CD28-cells. Both subsets were CD160 . Therefore, the CD27 CD45RA-subset contained central /low − + memory and memory cells in transition to effectors and was defined as memory subset (M) thereafter in the paper. CD27-CD45RA-CD8
" "
T cells were invariably CCR7-CD28-and expressed high levels of CD160. These cells may be considered as definitely engaged into + effector functions and we consequently named them effectors (E). Finally, CD27-CD45RA CD8 T cells were also CCR7-CD28-CD160
, and corresponded to terminally differentiated effector cells (TE).
We compared the distribution of M and E CD8 T cells before ( analysis) and following 48 hours of anti-CD3 stimulation of contrast, in the presence of Treg, the mean value of M/E ratio corresponded to 6.7 which was not significantly different from the one obtained for non-activated CD8 T cells (P>0.5), but was significantly higher than the M/E ratio of CD8 T cells activated alone or in the + + presence of T CD4 CD25-T cells (P<0.001, ).
Next, we repeated these experiments with sorted M (CD27 CD45RA-) and E (CD27-CD45RA-) CD8 T cells (n 4). These respectively; P<0.01), ( ). In contrast, Treg did not inhibit the maturation of E to TE CD8 T cells (E/TE ratio 1.6 and 2.2 in the Figure 3B presence of CD4 CD25-and Treg, respectively, P 0.08, ). Globally, these results indicate that Treg inhibited the differentiation of
M to E CD8 T cells upon polyclonal stimulation.
+
We have previously shown that the CD160 receptor is expressed by mature circulating or tissue effector cytotoxic CD8 T cells ;
. Therefore, we studied CD160 expression on CD8 T cell subsets differentiated from activated total CD8 T cells. Polyclonal stimulation of CD8 T cells cultured either alone or in the presence of CD4 CD25-T increased the percentage of CD160 CD8 T cells (mean 35 and
37 , respectively as compared to 21 under non-stimulated conditions n 9), (P<0.01). This effect was abolished in the presence of Treg
(mean 23 ), (not shown). Detailed analysis revealed that this effect was mainly due to a significant inhibition of the induction of CD 160 % expression on the M subset: mean 21 in the presence of Treg as compared to 35 in the presence of CD4 CD25-T cells, (P<0.01), % % + whereas no effect was noted on E CD8 T cells (mean 23 as compared to 26 respectively, P>0.05), ( ). In addition, we found + % % Figure 3C that Treg decreased the expression of surface CD107a, another marker associated with cytotoxic effector CD8 T cells (not shown), + confirming that Treg prevented the maturation of CD8 T effectors upon polyclonal stimulation.
We concluded that Treg might exert differential effects on CD8 T memory and effector subsets, thus changing their proportions at the + overall level. More specifically, Treg prevented the differentiation towards E phenotype and promoted the accumulation of M cells. M and E subsets resulting from activation of CD8 T cells may be from heterogeneous origin. Therefore, we repeated the above + experiments with sorted M (CD27 CD45RA-) and E (CD27-CD45RA-) cells. Similarly, we found that Treg inhibited preferentially the + proliferation of sorted E CD8 T cells as compared to M (mean inhibition: 25.5 versus 8.9, respectively; P<0.01; n 4) ( ).
Treg inhibit preferentially the proliferation of E CD8 T cells
=
Fig. 4C
Globally, these results confirmed that Treg prevent the accumulation of E cells, due to specific effects on CD8 subsets.
Treg inhibit preferentially the apoptosis of M CD8 T cells
+ Proliferation in response to strong stimulation is always accompanied by activation-induced cell death (AICD) that terminates clonal expansion. Therefore, we investigated whether Treg could protect similarly the various CD8 T cell subsets from AICD related to + anti-CD3 mAb stimulation. To this end, the apoptosis rate of total CD8 T cells from 8 healthy donors stimulated in vitro alone, or in the + presence of either CD4 CD25-T or Treg was quantified by Annexin V staining. At day 2, mean (ranges) percentage of anti-CD3 activated + CD8 Annexin V T cells was 23 (14 36 ), (not shown). In the presence of CD4 CD25-T cells, the rate of CD8 T cell apoptosis
increased to 28 (18 41 ), while Treg decreased this rate to 15 (7 21 , P<0.01), ( ). Analyses of the apoptosis rates of M, E or
TE anti-CD3 activated CD8 T cells, showed that Treg inhibited significantly M cell apoptosis (mean 15 as compared to 28 in the
presence of CD4 CD25-T cells, P<0.01) whereas no significant effects were noted for E and TE subsets ( ). These results
suggested that M and E CD8 T cells exhibit a different sensitivity to Treg-mediated modulation of apoptosis. However, since these experiments were performed with total CD8 T cells, we cannot rule out cell-cell interactions between different subsets. Therefore, new experiments were performed on sorted M and E T cells. We found in the presence of CD4 CD25-T cells a 19 decrease of apoptosis rate + % among M as compared to E T cells. This effect was up to 36 in the presence of Treg (P<0.05) ( ).
%
Fig. 5B
Treg inhibit the apoptosis of M CD8 T cells by affecting PD-1/PD-L1 signaling pathway + As the interaction between PD-1 and its ligand PD-L1 has been recently recognized as a key regulator of activated CD8 T cell + survival , we investigated whether this pathway might be involved in Treg -mediated protection of M CD8 T cells from apoptosis. 21 -23 + First, we studied the expression of these molecules on anti-CD3 stimulated total CD8 T cells. Both PD-1 and its ligand were up-regulated + upon activation, with a maximum at 48h, followed by a decrease to the initial levels (data not shown). While PD-L1 expression increased 5 17 uniformly and significantly in all CD8 subsets as compared to baseline levels (P<0.01), PD-1 was induced preferentially on the M and E + subsets (P<0.01). Moreover, PD-1 expression was significantly higher on activated M as compared to activated E CD8 T cells (MFI 47
). Based on this differential expression, PD-1 seemed a suitable target for subset-specific regulation of the Fig. 6A apoptosis rate.
Accordingly, anti-PD-1 mAb increased significantly the apoptosis rate of activated CD8 T cells (by a mean of 55 ; n 6 + % = experiments), while anti-PD-L1 mAb reduced this rate (by a mean of 41 ), as compared to control conditions ( ). These data
suggest that CD8 T cell AICD rate might be the consequence of PD-1/PD-L1 cis interactions. Co-culture of anti-CD3 activated CD8 T 
Discussion
In this paper we investigated the role of Treg on the proliferation, functional differentiation and apoptosis of healthy donor CD8 T + cell subsets. Firstly, we found that Treg inhibited the proliferation and effector function of CD8 T cells under polyclonal and activated and memory CD8 T cells . Furthermore, the ability of activated E cells to re-express CD27 is limited within a certain number + 28 of divisions, and the definite loss of this receptor indicates a truly advanced differentiation state . 3
The systematic analysis of M and E subsets in conditions of polyclonal stimulation showed that Treg effects are more complicated than a simple inhibition of cell proliferation. Indeed, Treg inhibited more importantly the accumulation of E as compared to M cells and apoptosis of this latter subset. Based on these results, it can be predicted that in the context of strong CD8 T cell activation, the presence + of Treg would maintain and/or increase the pool of memory CD8 T cells, and limit effector-cell differentiation resulting in a conserved presence of Treg, no such differences or even increased apoptosis were detected at the level of E and TE cells. Thus, these observations further reinforce the need to evaluate Treg effects at the subpopulation level as shown here.
The differential effects of Treg on M and E cells could be the consequence of some phenotypic differences between these subsets. In agreement with others , we have detected a significantly higher expression of PD-1 on the CD27 CD8 memory subset following 23
activation. This indicated that in spite of a potentially long life span, memory CD8 T cells are much more sensitive to negative regulation. 
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